Literature DB >> 1916886

Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers.

J J Gómez-Reino1, J Martínez-Laso, J L Vicario, E Paz-Artal, A Aragón, J M Martín-Villa, M D De Juan, P Pérez-Aciego, A Arnaiz-Villena.   

Abstract

HLA-DR3 antigen included in the compound phenotype B18BfF1 (but not the one linked to the B8BfS compound phenotype) was found to be significantly increased in our SLE patients. It is remarkable that in our Southern-Mediterranean population, B18BfF1DR3 individuals (but not B8BfSDR3) are prone to SLE with renal disease, in contrast with other Northern European and Caucasoid populations. Also, patients with autoantibodies to Ro/La have a significant increase of the B8DR3 compound phenotype. Production of autoantibodies against Ro alone was associated to DR2 and production of anti-Sm/nRNP to DR3 (either B18BfF1 or B8BfS associated) only in the subgroup without renal disease. The distinctive HLA and autoimmune associations to SLE with and without renal disease suggests that both clinical forms may not share a common identical pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916886     DOI: 10.1016/s0171-2985(11)80210-x

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus.

Authors:  Vaidehi R Chowdhary; Chao Dai; Ashenafi Y Tilahun; Julie A Hanson; Michele K Smart; Joseph P Grande; Govindarajan Rajagopalan; Shu-Man Fu; Chella S David
Journal:  J Immunol       Date:  2015-10-16       Impact factor: 5.422

Review 2.  Unraveling the genetics of systemic lupus erythematosus.

Authors:  John B Harley; Jennifer A Kelly; Kenneth M Kaufman
Journal:  Springer Semin Immunopathol       Date:  2006-09-22

3.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

4.  Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.

Authors:  J M Martín-Villa; J Martínez-Laso; M A Moreno-Pelayo; M J Castro-Panete; N Martínez-Quiles; M Alvarez; M D de Juan; J J Gómez-Reino; A Arnaiz-Villena
Journal:  Ann Rheum Dis       Date:  1998-04       Impact factor: 19.103

5.  Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. SLE Study Group members.

Authors:  Z Yao; A Kimura; K Hartung; P J Haas; A Volgger; G Brünnler; J Bönisch; E D Albert
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.

Authors:  J L Vicario; J Martinez-Laso; A Corell; J M Martin-Villa; P Morales; G Lledo; O G Segurado; D de Juan; A Arnaiz-Villena
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

7.  Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE).

Authors:  O G Segurado; A A Arnaiz-Villena; P Iglesias-Casarrubios; J Martinez-Laso; J L Vicario; G Fontan; M Lopez-Trascasa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.